{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:34:54Z","timestamp":1793385294837,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canrad.2021.08.012","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T19:39:38Z","timestamp":1640201978000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Radiotherapy of salivary gland tumours"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Larnaudie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-Y.","family":"Marcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Delaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Costes Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Troussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.-J.","family":"Bensadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vergez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Servagi Vernat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.08.012_bib0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.canrad.2018.07.141","article-title":"Delineation of the primary tumour clinical target volumes and neck node levels selection of parotid cancers","volume":"23","author":"Piram","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0195","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2018.08.020","article-title":"Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers","volume":"131","author":"Biau","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1748-717X-6-97","article-title":"Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region","volume":"6","author":"Vorwerk","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0205","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ijrobp.2006.10.044","article-title":"Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation?","volume":"67","author":"Chen","year":"2007","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.annpat.2014.01.006","article-title":"Pathologists and the French network of expertise on rare cancers ENT: the Refcorpath","volume":"34","author":"Badoual","year":"2014","journal-title":"Ann Pathol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1684\/bdc.2014.1956","article-title":"Cancers ORL rares et Refcor, R\u00e9seau d\u2019expertise fran\u00e7ais sur les cancers ORL rares","volume":"101","author":"Baujat","year":"2014","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2021.08.012_bib0220","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/hed.24484","article-title":"Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas","volume":"38","author":"Mifsud","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.08.012_bib0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canrad.2013.09.007","article-title":"Radiation therapy for pleomorphic adenoma of the parotid","volume":"18","author":"Jardel","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.anorl.2020.08.009","article-title":"Guidelines of the French society of otorhinolaryngology-head and neck surgery (SFORL), part II: management of recurrent pleomorphic adenoma of the parotid gland","volume":"138","author":"Malard","year":"2021","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.canrad.2021.08.012_bib0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.anorl.2020.08.009","article-title":"Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL), part II: management of recurrent pleomorphic adenoma of the parotid gland","volume":"138","author":"Malard","year":"2021","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.canrad.2021.08.012_bib0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.anorl.2020.09.002","article-title":"Guidelines of the French society of otorhinolaryngology-head and neck surgery (SFORL), part I: primary treatment of pleomorphic adenoma","volume":"138","author":"Vergez","year":"2021","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.canrad.2021.08.012_bib0245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.critrevonc.2014.02.002","article-title":"A rationale for chemoradiation (vs. radiotherapy) in salivary gland cancers? On behalf of the Refcor (French rare head and neck cancer network)","volume":"91","author":"Cerda","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(96)00464-6","article-title":"Postoperative radiotherapy for malignant tumors of the parotid gland","volume":"37","author":"Garden","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.012_bib0255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijrobp.2004.03.018","article-title":"The role of radiotherapy in the treatment of malignant salivary gland tumors","volume":"61","author":"Terhaard","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.012_bib0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0265","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.canrad.2019.05.013","article-title":"Proposal for the selection and delineation of clinical target volumes for the radiotherapy of submandibular gland tumours","volume":"23","author":"Fr\u00e9d\u00e9ric-Moreau","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0270","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2006.06.050","article-title":"Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas","volume":"66","author":"Chen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.08.012_bib0275","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13014-018-1130-y","article-title":"Nodal failure patterns and utility of elective nodal irradiation in submandibular gland carcinoma treated with postoperative radiotherapy\u00a0\u2013\u00a0a multicenter experience","volume":"13","author":"Hsieh","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0280","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO;2-9","article-title":"The indications for elective treatment of the neck in cancer of the major salivary glands","volume":"69","author":"Armstrong","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2021.08.012_bib0285","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.canrad.2007.07.002","article-title":"Postoperative treatment of malignant tumors of the parotid gland: radiotherapy, concomitant chemotherapy and radiation therapy?","volume":"11","author":"Bouyon","year":"2007","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0290","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.semradonc.2012.03.009","article-title":"Biology and management of salivary gland cancers","volume":"22","author":"Adelstein","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0295","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/j.canrad.2016.07.005","article-title":"Radiotherapy of carcinoma of the salivary glands","volume":"20","author":"Servagi-Vernat","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0305","first-page":"141","article-title":"Indications for salivary gland radiotherapy","volume":"78","author":"Thomson","year":"2016","journal-title":"Adv Otorhinolaryngol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.oraloncology.2016.06.019","article-title":"Salivary Gland. Photon beam and particle radiotherapy: present and future","volume":"60","author":"Orlandi","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0315","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.canrad.2018.06.015","article-title":"Image-guided radiotherapy for head and neck carcinoma","volume":"22","author":"Beddok","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0320","article-title":"Organs at risk dose-constraints","volume":"26","author":"No\u00ebl","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0325","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.canrad.2016.07.066","article-title":"Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible","volume":"20","author":"Pointreau","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0330","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.canrad.2013.03.008","article-title":"Organs at risk in radiation therapy of head and neck tumors: practical aspects in their delineation and normal tissue tolerance","volume":"17","author":"Servagi-Vernat","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0335","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.canrad.2016.08.124","article-title":"Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus","volume":"20","author":"Boisselier","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0340","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.canrad.2016.06.005","article-title":"Indications and results for protontherapy in cancer treatments","volume":"20","author":"Doyen","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0345","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.canrad.2016.06.004","article-title":"Head and neck intensity-modulated radiation therapy: normal tissues dose constraints. Pharyngeal constrictor muscles and larynx","volume":"20","author":"Graff","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0350","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.canrad.2016.07.077","article-title":"Intensity modulated radiotherapy for head and neck cancer, dose constraint for normal tissue: cochlea vestibular apparatus and brainstem","volume":"20","author":"Guimas","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0355","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.canrad.2016.07.079","article-title":"Intensity-modulated radiotherapy of head and neck cancers: dose effects on the ocular, orbital and eyelid structures","volume":"20","author":"Thariat","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0360","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"Delineation of organs at risk and dose constraints","volume":"20","author":"No\u00ebl","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.08.012_bib0365","doi-asserted-by":"crossref","first-page":"102959","DOI":"10.1016\/j.critrevonc.2020.102959","article-title":"Major and minor salivary gland tumours","volume":"152","author":"Gatta","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2021.08.012_bib0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.canrad.2021.10.005","article-title":"Management and work-up procedures of patients with head and neck malignancies treated by radiation","volume":"26","author":"Gr\u00e9goire","year":"2022","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821002018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:34:52Z","timestamp":1761136492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821002018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1278321821002018"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.08.012","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy of salivary gland tumours","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}